|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
40.500 +0.500 (+1.250%) Ranking Overview
Ranking based on 11 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
1
|
Buy (2)
9
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 82.00 RMB (cts) | |
| Net Profit | 3,356.08 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 4,510.00 | 112.00 | 0 | -- | 4,878.00 | 4,369.00 |
| 2026 | 5,198.00 | 128.00 | 0 | -- | 6,024.00 | 5,027.00 |
| 2027 | 6,229.00 | 151.00 | 0 | -- | 7,266.00 | 5,811.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 4,878.00 | 120.00 | -- | JP MORGAN | Overweight | 51.00 | 13/02/2026 | |
| 2025 | 4,481.54 | 121.00 | -- | JEFFERIES HK | Buy | 50.00 | 08/10/2025 | |
| 2025 | 4,369.00 | 106.00 | -- | CLSA | OutPerform | 48.50 | 11/02/2026 | |
| 2025 | 4,510.00 | 111.00 | -- | HAITONG | OutPerform | 48.18 | 31/08/2025 | |
| 2025 | 4,726.00 | 116.00 | -- | UBS | Buy | 46.90 | 12/01/2026 | |
| 2025 | 4,568.00 | 112.00 | -- | HSBC | Buy | 45.00 | 26/09/2025 | |
| 2025 | 4,380.00 | 105.00 | -- | MORGAN STANLEY | Overweight | 45.00 | 03/02/2026 | |
| 2025 | 4,695.00 | 116.60 | -- | DAIWA | Buy | 42.00 | 12/01/2026 | |
| 2025 | 4,728.00 | 115.00 | -- | BANK OF AMERICA | Neutral | 41.80 | 13/01/2026 | |
| 2025 | 4,474.00 | 106.70 | -- | CCBI | OutPerform | 39.00 | 26/08/2025 | |
| 2025 | 4,497.00 | 110.00 | -- | NOMURA | Buy | 37.36 | 28/11/2025 | |
| 2026 | 6,024.00 | 150.00 | -- | JP MORGAN | - | -- | 13/02/2026 | |
| 2026 | 5,387.68 | 146.00 | -- | JEFFERIES HK | - | -- | 08/10/2025 | |
| 2026 | 5,692.00 | 138.00 | -- | CLSA | - | -- | 11/02/2026 | |
| 2026 | 5,198.00 | 128.00 | -- | HAITONG | - | -- | 31/08/2025 | |
| 2026 | 5,493.00 | 135.00 | -- | UBS | - | -- | 12/01/2026 | |
| 2026 | 5,138.00 | 123.00 | -- | MORGAN STANLEY | - | -- | 03/02/2026 | |
| 2026 | 5,167.00 | 127.00 | -- | HSBC | - | -- | 26/09/2025 | |
| 2026 | 5,421.00 | 134.60 | -- | DAIWA | - | -- | 12/01/2026 | |
| 2026 | 5,159.00 | 126.00 | -- | BANK OF AMERICA | - | -- | 13/01/2026 | |
| 2026 | 5,027.00 | 119.90 | -- | CCBI | - | -- | 26/08/2025 | |
| 2026 | 5,112.00 | 125.00 | -- | NOMURA | - | -- | 28/11/2025 | |
| 2027 | 7,266.00 | 181.00 | -- | JP MORGAN | - | -- | 13/02/2026 | |
| 2027 | 6,460.98 | 171.00 | -- | JEFFERIES HK | - | -- | 08/10/2025 | |
| 2027 | 7,011.00 | 170.00 | -- | CLSA | - | -- | 11/02/2026 | |
| 2027 | 6,049.00 | 149.00 | -- | HAITONG | - | -- | 31/08/2025 | |
| 2027 | 6,757.00 | 166.00 | -- | UBS | - | -- | 12/01/2026 | |
| 2027 | 6,017.00 | 148.00 | -- | HSBC | - | -- | 26/09/2025 | |
| 2027 | 6,229.00 | 149.00 | -- | MORGAN STANLEY | - | -- | 03/02/2026 | |
| 2027 | 6,522.00 | 162.00 | -- | DAIWA | - | -- | 12/01/2026 | |
| 2027 | 6,219.00 | 151.00 | -- | BANK OF AMERICA | - | -- | 13/01/2026 | |
| 2027 | 6,078.00 | 145.00 | -- | CCBI | - | -- | 26/08/2025 | |
| 2027 | 5,811.00 | 142.00 | -- | NOMURA | - | -- | 28/11/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/02/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,339,266 |
| %Change | 56.047% |
| EPS / (LPS) | RMB 0.580 |
| NBV Per Share (¥) | RMB 11.048 |